GGrantIndex
Sort

16,251 grants matching traumatic brain injury

Leveraging Biomarkers of Traumatic Brain Injury in Adults to Assess Cerebral Injury in Children with Sickle Cell Disease

$210,795
James F Casella · Johns Hopkins University · R21 · FY2020 · HD

Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors

$210,752
Michael W. Graner · University Of Colorado Denver · R21 · FY2019 · MH

Regulation of Neuroinflammation by Meningeal Lymphatics

$210,750
Zsuzsanna Fabry · University Of Wisconsin-Madison · R01 · FY2024 · NS

An Acute Neurobehavioral Program for Improving Functional Status after TBI

$210,644
Janet P. Niemeier · Virginia Commonwealth University · R01 · FY2011 · HD

Is u-calpain a pathologic isoform?

$210,629
James W Geddes · University Of Kentucky · P01 · FY2011 · NS

Is u-calpain a pathologic isoform?

$210,626
James W Geddes · University Of Kentucky · P01 · FY2010 · NS

Role of Cortical Microvascular Lesions in Amyloid-Beta Accumulation

$210,430
Chris B Schaffer · Cornell University · R21 · FY2009 · NS

Peptide therapy for alcohol-induced CNS injury

$210,306
Mohammed Abdul Muneer · Hackensack University Medical Center · R21 · FY2024 · AA

Non invasive in vivo imaging of pathological fibrin deposition in the human brain

$210,000
Caterina Mainero · Massachusetts General Hospital · R21 · FY2022 · NS

SCH: INT: Collaborative Research: An Intelligent Pervasive Augmented reaLity therapy (iPAL) for Opioid Use Disorder and Recovery

$210,000
Ranjana K Mehta · Texas A&M Engineering Experiment Station · · FY2020 · CSE

Restoring Normal Output After Traumatic Brain Injury

$210,000
Akiva S Cohen · Children'S Hosp Of Philadelphia · R21 · FY2017 · NS

Resilient Together; Developing a resiliency skills program for dyads of patients with young onset dementia and their family caregivers

$209,995
Ana-Maria Vranceanu · Massachusetts General Hospital · R21 · FY2019 · NR

VALIDATION OF THE MILITARY ACUTE CONCUSSION EVALUATION (MACE) FOR THE IN-THEATER EVALUATION OF COMBAT-RELATED TRAUMATIC BRAIN INJURY

$209,961
Prohealth Waukesha Memorial Hospital, Inc. · · FY2008 · Department of the Army

Core 2d Traumatic Brain Injury - Driving Biological Project

$209,873
John Van Horn · Brigham And Women'S Hospital · U54 · FY2013 · EB

Disseminating a validated mouthguard sensor to investigate the effect of head impacts on brain health

$209,802
David Camarillo · Stanford University · R24 · FY2019 · NS

Elucidate Consequences of Autoimmune Response to Protease-modified GFAP in TBI

$209,800
Kevin Ka Wang Wang · University Of Florida · R21 · FY2014 · NS

Project 9: Using Socially Assistive Robot Assistants to Augment NeuroRehabilitation Exercise Therapy

$209,774
David Feil-Seifer · University Of Nevada Reno · P20 · FY2017 · GM

Development of a software package for speech therapy.

$209,650
Andrew Michael Sloan · Vulintus, Llc · R43 · FY2014 · DC

A novel inflammatory cell with neuroprotective and neuroregenerative properties

$209,542
Benjamin Matthew Segal · Ohio State University · R01 · FY2019 · EY

Biomarker Core

$209,517
Lynn Bekris · Cleveland Clinic Lerner Com-Cwru · P30 · FY2019 · AG

Biophysical Studies of Non-Invasive Brain Cell Stimulation with Focused Ultrasound

$209,450
Jerome Jacques Lacroix · Western University Of Health Sciences · R21 · FY2018 · NS

Analysis of blood biomarkers of Alzheimer's and other dementias following traumatic brain injury and/or blast exposure in military personnel

$209,382
Jack W Tsao · University Of Tennessee Health Sci Ctr · R21 · FY2019 · NS

Role of Sarm1 in TBI-accentuated C9orf72 Frontotemporal Dementia

$209,375
Nils Henninger · Univ Of Massachusetts Med Sch Worcester · R21 · FY2024 · NS

Trigeminal nerve stimulation to modulate cortical spreading depolarizations after brain injury

$209,375
Chunyan Li · Feinstein Institute For Medical Research · R21 · FY2020 · NS

MIF20-loaded nanoparticles for TBI treatment

$209,375
Jiangbing Zhou · Yale University · R21 · FY2017 · NS